The Blacklisting of Peptides You may have seen headlines recently claiming peptides like MOTS C or BPC 157 are back let's talk about what this means. In 2023, the FDA placed 19 commonly used peptides into Category Pharmacy Purchasing & Products Magazine FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner A new FDA advisory panel meeting, influenced by RFK Jr.'s push for broader access, will weigh the potential benefits and risks of widely promoted peptides. Click the link in bio to read